PATTERNS OF PROGRESSION IN GLIOBLASTOMA PATIENTS UNDERGOING IMMUNE CHECKPOINT INHIBITOR THERAPY

被引：0
|
作者：
Rochand, Adrien [1 ]
Baldini, Capucine [2 ]
Touat, Mehdi [3 ]
机构：
[1] Hop Europeen Georges Pompidou, Paris, Ile De France, France
[2] Gustave Roussy, Drug Dev Dept DITEP, Villejuif, France
[3] Hop Univ La Pitie Salpetriere, Paris, France
来源：
NEURO-ONCOLOGY | 2023年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
NIMG-60
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Exploring the clinical significance of specific immune-related adverse events in melanoma patients undergoing immune checkpoint inhibitor therapy
    Asher, Nethanel
    Bar-Hai, Neta
    Ben-Betzalel, Guy
    Stoff, Ronen
    Grynberg, Shirly
    Schachter, Jacob
    Frommer-Shapira, Ronnie
    MELANOMA RESEARCH, 2024, 34 (05) : 439 - 449
  • [32] Utility of serum CA-125 monitoring in patients with ovarian cancer undergoing immune checkpoint inhibitor therapy
    Boland, Julia L.
    Zhou, Qin
    Iasonos, Alexia E.
    O'Cearbhaill, Roisin E.
    Konner, Jason
    Callahan, Margaret
    Friedman, Claire
    Aghajanian, Carol
    Sabbatini, Paul
    Zamarin, Dmitriy
    Cadoo, Karen A.
    GYNECOLOGIC ONCOLOGY, 2020, 158 (02) : 303 - 308
  • [33] Patterns and outcomes of subsequent therapy after immune checkpoint inhibitor discontinuation in HCC
    Sharma, Rohini
    Pillai, Anjana
    Marron, Thomas Urban
    Fessas, Petros
    Saeed, Anwaar
    Jun, Tomi
    Dharmapuri, Sirish
    Szafron, David
    Naqash, Abdul Rafeh
    Gampa, Anuhya
    Wang, Yinghong
    Khan, Uqba
    Muzaffar, Mahvish
    Lee, Chieh-Ju
    Lee, Pei-Chang
    Bulumulle, Anushi
    Paul, Sonal
    Bettinger, Dominic
    Hildebrand, Hannah
    Yehia, Mohammed
    Pressiani, Tiziana
    Kaseb, Ahmed
    Huang, Yi-Hsiang
    Ang, Celina
    Kudo, Masatoshi
    Nishida, Naoshi
    Personeni, Nicola
    Rimassa, Lorenza
    Pinato, David James
    HEPATOLOGY COMMUNICATIONS, 2022, 6 (07) : 1776 - 1785
  • [34] A study on the impact of antibiotics on the efficacy and prognosis of advanced lung cancer patients undergoing immune checkpoint inhibitor therapy
    Xie, Yufang
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [35] Machine Learning Approaches for Assessing Risk Factors of Adrenal Insufficiency in Patients Undergoing Immune Checkpoint Inhibitor Therapy
    Kim, Woorim
    Cho, Young Ah
    Min, Kyung Hyun
    Kim, Dong-Chul
    Lee, Kyung-Eun
    PHARMACEUTICALS, 2023, 16 (08)
  • [36] Obesity paradox in patients with non-small cell lung cancer undergoing immune checkpoint inhibitor therapy
    Lee, Ji Hyun
    Kang, Danbee
    Ahn, Jin Seok
    Guallar, Eliseo
    Cho, Juhee
    Lee, Ho Yun
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2023, 14 (06) : 2898 - 2907
  • [37] The inflammatory tumor microenvironment in patients with solid tumors with brain metastases after progression to immune checkpoint inhibitor therapy
    Starzer, A. M.
    Kleinberger, M.
    Feldmann, K.
    Tomasich, E.
    Hatziioannou, T.
    Paiato, C.
    Heller, G.
    Kreminger, J.
    Traint, S.
    Steindl, A.
    Ressler, J. M.
    Widhalm, G.
    Gatterbauer, B.
    Dieckmann, K.
    Muellauer, L.
    Preusser, M.
    Berghoff, A. S.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 272 - 272
  • [38] Association of Immune Checkpoint Inhibitor Treatment and Emphysema Progression in Patients With Urothelial Cancer
    Zo, S.
    Kang, D.
    Oh, Y.
    Seo, S.
    Jeong, B.
    Park, S.
    Cho, J.
    Lee, H.
    Park, H.
    Shin, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [39] Tumor assessment in immune checkpoint inhibitor therapy. Tumor response, progression and pseudoprogression
    Foller, S.
    Oppel-Heuchel, H.
    Grimm, M. -O.
    UROLOGE, 2018, 57 (11): : 1316 - 1325
  • [40] Hyper Progression of Squamous Cell Carcinoma After Initiation of Immune Checkpoint Inhibitor Therapy
    Soni, S.
    Tosonian, S.
    Perumbeti, A.
    Tsai, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
12345